Table 2.
Compound Category | # of Compounds |
---|---|
Total compounds in primary screen | 40,879 |
| |
Total hits (SD >3 or % inhibition >30%) | 1665 |
Flagged cytoxic compounds | −27a |
Promiscuous compounds (SD > 3 in ≥ 10 previous screens) | −216 |
Maleimide containing compounds | −23 |
| |
Total compounds in confirmation screen | 1399 (3.4 %) |
| |
Total hits (median % inhibition > 30%) | 595 |
Generally promiscuous compounds (> 30% inhibition in ≥ 10 previous screens) | −67 |
Large compounds (topological polar surface area ≥ 140 Å2) | −14 |
Compounds with limited availability | −18 |
| |
Total compounds for counter screens | 496 (1.2 %) |
| |
Sulfhydryl-reacting or MMBC-CoA quenching compounds (% inhibition ≥ 30%) | −54 |
Metal chelators (% inhibition < 30%) | −81 |
8-hydroxyquinoline containing compounds | −20 |
Compounds with limited availability | −3 |
| |
Total compounds analyzed for dose response | 338 (0.8 %) |
| |
Total hits (compounds with sigmoidal dose response curves) | 266 |
Compounds with pAC50 values <4.5 (IC50 >31.6 μM) | −86 |
Compounds with Hill slope values <−2.0 | −59 |
| |
Compounds for follow-up studies | 122 (0.3 %) |
A minus (−) sign before the number indicates that the number of compounds eliminated from further consideration at this step.